Open letter from ATAC to Abbott's CEO, Miles White.
Dee
Lynda
L
Sharp
Matt
M
D000288:Administrative Personnel; D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics; D017320:HIV Protease Inhibitors / Q000191:economics*; D019438:Ritonavir / Q000191:economics*; D014481:United States
D017320:HIV Protease Inhibitors; D019438:Ritonavir